Dustan, H.P. , AND Page, I.H.: A new, potent antihypertensive drug. J. A. M. A., 170: 1265, 1959.
2.
Dollery, C.T. , Emslie-Smith, D., AND Nilne, M.D.Clinical and pharmacological studies with guanethidine in treatment of hypertension. Lancet, 2: 381, 1960.
3.
Leishman, A.W. , Mathews, H.L., AND Smith, A.V.: Guanethidine: hypotensive drug with prolonged action. Lancet, 2: 1044, 1959.
4.
Evanson, V.M. , AND Sears, H.T.: Comparison of bretylium tosylate with guanethidine in treatment of severe hypertension. Lancet , 2: 387, 1960.
5.
Page, I.H., AND Dustan, H.P.: Current status of bretylium and guanethidine as antihypertensive drugs . Circulation, 22: 181, 1960.
6.
Richardson, D.W., Wyso, E.M., Magee , V.H., AND Cavell, G.C.: Circulatory effect of guanethidine: clinical, renal, and cardiac response to treatment with a novel antihypertensive drug . Circulation, 22: 184, 1960.
7.
Vernikos-Danellis, V., AND Zamis, E.: Some pharmacological actions of bretylium and guanethidine. Lancet, 2: 787, 1960.
8.
Page, I.H.: The prolonged use of guanethidine. M. Clin. NorthAmerica , 45: 417, 1961.
9.
Fertig, H., Fletcher, L., Schvartz, N., Torosdag, S., Spencer, T.B., AND Bry-Ant, V.M.: Clinical experiences with guanethidine in ambulatory hypertensive subjects . New England J. Med., 265: 268, 1961 .
10.
Gaffney, T.E. , Braunwald, E., AND Kah-Ler, R.L.: Effects of guanethidine on triiodothyronine-induced hyperthyroidism in man. New England J. Med., 265: 16, 1961.